亚太瞬时蛋白表达市场预测至 2031 年 - 区域分析 - 按产品类型(仪器、试剂、表达载体和感受态细胞)、应用(基因组研究、基因治疗、生物生产、癌症研究和药物开发)和最终用户(制药和生物技术公司、学术和研究机构以及临床研究组织)

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 152    |    Report Code: TIPRE00022176    |    Category: Life Sciences

Asia Pacific Transient Protein Expression Market
2023 年亚太地区瞬时蛋白表达市场价值为 1.8105 亿美元,预计到 2031 年将达到 2.9426 亿美元;预计 2023 年至 2031 年的复合年增长率为 6.3%。

用于治疗性蛋白生产的植物表达系统推动亚太地区瞬时蛋白表达市场发展

在重组蛋白生产过程中,使用微生物或哺乳动物细胞表达系统一直是一种常见的做法;然而,近年来,植物表达已被推广为一种具有成本效益、可扩展、安全和可持续的替代方案。由于瞬时表达方法的创造和进步,蛋白质合成时间大大缩短,植物中重组蛋白的产量也得到了提高。消费者偏好向植物产品的转变迫使制药和生物制药公司专注于植物基治疗性蛋白的合成。植物的使用具有极好的潜力,可以提高蛋白质的产量,这些蛋白质可用于预防或治疗人类和动物疾病。由于监管框架的不断重组和人们对植物中瞬时蛋白质表达的认识不断提高,未来几年治疗性蛋白质在医疗保健领域的使用可能会激增。最大程度的扩大规模可能性、低生长成本、复杂的蛋白质生产能力、低污染(尤其是涉及人类病原体)风险和优化的生长条件是植物瞬时蛋白质表达的主要优势。此外,与其他表达系统相比,植物被认为更安全,因为它们不会产生内毒素,对人体的危害更小。因此,用于治疗性蛋白质表达的植物表达系统在预测期内将成为瞬时蛋白质表达市场增长的重要机会。

亚太地区瞬时蛋白质表达市场概览

亚太地区的瞬时蛋白质表达市场细分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。该地区的市场增长归因于亚太地区多个国家的生物技术产业不断发展、软件产品发布不断增加以及瞬时蛋白表达系统的不断发展和改进。

亚太地区瞬时蛋白表达市场收入及预测至 2031 年(百万美元)

亚太地区瞬时蛋白表达市场细分

亚太地区瞬时蛋白表达市场分为产品类型、应用、最终用户和国家/地区。

根据产品类型,亚太地区瞬时蛋白表达市场细分为仪器、试剂、表达载体和感受态细胞。仪器部分在 2023 年占据了最大的市场份额。

在应用方面,亚太地区瞬时蛋白表达市场细分为基因组研究、基因治疗、生物生产、癌症研究和药物开发。基因组研究领域在 2023 年占据了最大的市场份额。

根据最终用户,亚太地区瞬时蛋白表达市场细分为制药和生物技术公司、学术和研究机构以及临床研究组织。制药和生物技术公司部门在 2023 年占据了最大的市场份额。

按国家/地区划分,亚太地区瞬时蛋白表达市场细分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。中国在 2023 年占据了亚太地区瞬时蛋白表达市场份额的主导地位。

赛默飞世尔科技公司、默克集团、QIAGEN NV、GenScript Biotech Corporation、Promega Corp、Takara Bio Inc、New England Biolabs、安捷伦科技公司、Mirus Bio LLC、Bio-Rad Laboratories Inc、Lonza Group AG 和 MaxCyte Inc 是亚太地区瞬时蛋白表达市场的一些领先公司。

Asia Pacific Transient Protein Expression Strategic Insights

Strategic insights for Asia Pacific Transient Protein Expression involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-transient-protein-expression-market-strategic-framework.webp
Get more information on this report

Asia Pacific Transient Protein Expression Report Scope

Report Attribute Details
Market size in 2019 US$ 97.4 Million
Market Size by 2027 US$ 151.9 Million
Global CAGR (2020 - 2027) 5.9%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 产品类型
  • 仪器
  • 试剂
  • 表达载体
  • 感受态细胞
By 应用
  • 基因组研究
  • 基因治疗
  • 生物生产
  • 癌症研究
  • 药物开发
By 最终用户
  • 制药和生物技术公司
  • 学术和研究机构
  • 临床研究组织
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc.
  • MERCK KGaA
  • QIAGEN
  • GenScript
  • Promega Corporation
  • Takara Bio Inc.
  • MERIDIAN BIOSCIENCE, INC.
  • New England Biolabs
  • Agilent Technologies, Inc.
  • Mirus Bio LLC
  • Get more information on this report

    Asia Pacific Transient Protein Expression Regional Insights

    The regional scope of Asia Pacific Transient Protein Expression refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-transient-protein-expression-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Transient Protein Expression Market

    • Thermo Fisher Scientific Inc     
    • Merck KGaA                                      
    • QIAGEN NV                                          
    • GenScript Biotech Corporation     
    • Promega Corp                                     
    • Takara Bio Inc                                     
    • New England Biolabs             
    • Agilent Technologies Inc         
    • Mirus Bio LLC                                
    • Bio-Rad Laboratories Inc          
    • Lonza Group AG
    • MaxCyte Inc
    Frequently Asked Questions
    How big is the Asia Pacific Transient Protein Expression Market?

    The Asia Pacific Transient Protein Expression Market is valued at US$ 97.4 Million in 2019, it is projected to reach US$ 151.9 Million by 2027.

    What is the CAGR for Asia Pacific Transient Protein Expression Market by (2020 - 2027)?

    As per our report Asia Pacific Transient Protein Expression Market, the market size is valued at US$ 97.4 Million in 2019, projecting it to reach US$ 151.9 Million by 2027. This translates to a CAGR of approximately 5.9% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Transient Protein Expression Market report typically cover these key segments-

  • 产品类型 (仪器, 试剂, 表达载体, 感受态细胞)
  • 应用 (基因组研究, 基因治疗, 生物生产, 癌症研究, 药物开发)
  • 最终用户 (制药和生物技术公司, 学术和研究机构, 临床研究组织)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Transient Protein Expression Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Transient Protein Expression Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in Asia Pacific Transient Protein Expression Market?

    The Asia Pacific Transient Protein Expression Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Thermo Fisher Scientific Inc.
  • MERCK KGaA
  • QIAGEN
  • GenScript
  • Promega Corporation
  • Takara Bio Inc.
  • MERIDIAN BIOSCIENCE, INC.
  • New England Biolabs
  • Agilent Technologies, Inc.
  • Mirus Bio LLC
  • Sino Biological Inc.
  • Who should buy this report?

    The Asia Pacific Transient Protein Expression Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Transient Protein Expression Market value chain can benefit from the information contained in a comprehensive market report.